pillbase.ru

Tybost

Active substance: cobicistat

TABLET, FILM COATED · COBICISTAT 150 mg/1

United StatesActive

Marketing holder: Gilead Sciences, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-№(005222)-(РГ-RU)
    Гилеад Сайенсиз Интернешнл Лимитед
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-005722
    Гилеад Сайенсиз Интернешнл Лимитед
EU 6
  • Evotaz
    cobicistat, atazanavir
    EMEA/H/C/003904
    Bristol-Myers Squibb Pharma EEIG
  • Genvoya
    elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide
    EMEA/H/C/004042
    Gilead Sciences Ireland UC
  • Rezolsta
    darunavir, cobicistat
    EMEA/H/C/002819
  • Stribild
    elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate
    EMEA/H/C/002574
    Gilead Sciences Ireland UC
  • Symtuza
    darunavir, cobicistat, emtricitabine, tenofovir alafenamide
    EMEA/H/C/004391
    Janssen-Cilag International
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-970a-723e-a238-d6719e7be5ad;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
61958-1401
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 61958-1401 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 61958-1401 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 61958-1401 · Verified 2026-10-09 · open in source